NDC 63323-965-01 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-965
- Requested NDC
- 63323-965-01
- Package NDCs from labels
- 63323-965-01, 63323-965-05, 63323-965-03, 63323-965-10, 63323-965-02, 63323-965-20
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2025-08-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE, USP | Henry Schein, Inc. | 2025-08-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Potassium Chloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-02-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Potassium Chloride - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - General Injectables & Vaccines, Inc. | General Injectables & Vaccines, Inc. | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-965-01 | Potassium Chloride | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 5 | 5 | |
| 63323-965-02 | Potassium Chloride | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 20 | 5 | |
| 63323-965-03 | Potassium Chloride | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 10 | 5 | |
| 63323-965-05 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 | |
| 63323-965-10 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 | |
| 63323-965-20 | Potassium Chloride | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-965-01 | ML - Milliliter | 63323-965 | 1bbfa031-5c7d-4660-bfc1-4d4f0c7b4049 | 1 | 2019-10-07 |
| 63323-965-02 | ML - Milliliter | 63323-965 | eb59be88-d60b-48d6-ae5b-4790007c02c5 | 1 | 2019-09-05 |
| 63323-965-03 | ML - Milliliter | 63323-965 | f645fe1e-bd3d-4cdc-99db-7744f42ecbab | 1 | 2019-10-07 |
| 63323-965-05 | ML - Milliliter | 63323-965 | 1908bab0-016a-48b3-93bc-249396e92c07 | 1 | 2012-07-24 |
| 63323-965-10 | ML - Milliliter | 63323-965 | 8be2fd64-e5a7-4231-b851-2399e724fac7 | 1 | 2012-07-24 |
| 63323-965-20 | ML - Milliliter | 63323-965 | 346766e4-da06-4c17-94c3-4ef8fe05b96e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | American Health Packaging | 7956883f-0d31-4081-bbea-d9ea320a193b | 2025-08-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals Inc | 3e78028d-21a0-ba0f-e063-6294a90aac49 | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals, Inc. | 3e8a6f61-44eb-4b5a-e063-6294a90a4b1b | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3b403d60-4246-d765-e063-6394a90a12e8 | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 162a8ab5-76cf-48fa-8487-7780ed65647e | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 14db14ba-fd0d-4b2a-9f1c-a62b3b82306f | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | 660YQ98I10 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | 660YQ98I10 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 8baf3f25-c78b-6c08-e053-2995a90a667e | 2025-07-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 8bb030b7-104a-373b-e053-2995a90ab580 | 2025-07-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Guardian Drug Company | 296eda62-ea8e-7a0c-e063-6294a90a9274 | 2025-07-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Genus Lifesciences | 14cd12ee-a4a3-465a-9550-58c9ef0e4f21 | 2025-07-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Schuessler Tissue Salts Kali Mur Glandular Tonic 5 | KALI MURIATICUM | Martin & Pleasance Pty Ltd | f4e2df47-0c8f-48c5-b6f3-2bd1e68afb89 | 2025-07-18 | Warnings | 660YQ98I10 |
| Potassium chloride | POTASSIUM CHLORIDE | Camber Pharmaceuticals, Inc. | fb2f6e74-4c1f-40c5-88a1-b88c069d4c75 | 2025-07-17 | Warnings, Adverse reactions | 660YQ98I10 |
| potassium chloride | POTASSIUM CHLORIDE | Solco Healthcare LLC | 52d91d76-8c7f-40f1-9f5c-e05962cabedd | 2025-07-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | 616f0de7-8843-44a1-8fa6-274d889286aa | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | 1ff53330-065c-4213-9c0c-ac498621d09d | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | e61a4522-b91d-400a-952c-6f035e4610dd | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON M | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | b89910f6-4ff5-4a62-8269-696f7c10e4f6 | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.